Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
about
Combating antimicrobial resistance: policy recommendations to save livesCiprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studiesReview of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infectionsCommunity-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Prevalence and risk factors for extended spectrum Beta-lactamase-producing uropathogens in patients with urinary tract infection.Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infectionsRisk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring systemMultiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies.Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission.Do we really know the prevalence of multi-drug resistant Escherichia coli in the territorial and nosocomial population?Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control.Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011.[Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.Incidence of sepsis following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in LebanonPrediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital.Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications.Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.Multidrug resistance found in extended-spectrum beta-lactamase-producing Enterobacteriaceae from rural water reservoirs in Guantao, China.Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from rural well water in Taian, China, 2014.Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.Risk factors that influence the empirical treatment of patients with acute pyelonephritis: a cohort study.Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.Antimicrobial Susceptibilities of Enterobacteriaceae in Community-Acquired Urinary Tract Infections during a 5-year Period: A Single Hospital Study in Korea.Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients.Presence of disinfectant resistance genes in Escherichia coli isolated from retail meats in the USA.Antibiotic resistance in urinary tract infections in college students.
P2860
Q24632857-3DD5D4CE-B349-4F2C-8628-3B0C729B8749Q26775453-999D3947-6175-4768-BCD3-CF988D534176Q26996226-1880645D-EDFD-425B-8A3C-FE5591BA9603Q30358381-36A915A3-A395-4CF0-9A74-C00DE664464DQ33622976-C57BF0F1-5B94-4FBD-9DC2-461C7EEA53E6Q34009487-533510E5-DB38-49D6-A1AE-38EAF2338031Q34459919-5750FF2D-4510-45CC-A6EF-EFE83F562805Q34920553-86F0DBB8-8550-41F8-95BB-FFE812C1299DQ35065875-26AABE5E-0EFE-4A1E-BAAF-7B80B81EBF1EQ35567738-DAC064EB-A078-4B66-A994-912485DA725DQ35689050-6DBE75A2-F741-41E2-B13E-71CA2B8E1273Q36180580-1D69C842-F91F-4223-97BD-BEF4A7854988Q36337074-8F1A6EDA-1536-408C-B7BC-7CE1161B49BCQ36810340-CCB0DB4B-196F-495D-AC74-3C582124451DQ36813752-591CBA76-12AF-4FE2-8A2D-260F17838FC5Q37003998-B171A986-50AC-4DE3-9F1A-26F3743B7B39Q37023242-C6ACAE2D-B28D-4475-B1D7-8C446A625494Q37036459-2B31AF9D-2D3A-471D-9525-C0D82CB3167AQ37196254-A1D1DBA7-B0FD-4414-844F-94E42DD0E2CBQ37263346-06DA333E-E4CE-4B4D-A9B8-340C72AD0A95Q37334691-D9419101-D609-4B4D-A6BD-4B46582E0883Q37518263-99D21DF0-D5F3-4D19-A67B-8BE2159E6795Q38074212-6C3D8879-1199-4C50-85F4-F8BC9D7D1693Q38497797-396BBBD6-BD19-43E1-B754-5F3F27E1A74EQ39525501-A6A838A0-E522-4E99-8BB0-0EC2119C226CQ39619985-7C94E55C-C36D-4627-8748-D7BA7A7ACEF2Q40053362-4BFEEE68-62DB-49B1-974B-4505B21718A8Q40066430-B783454F-7156-4903-A274-27B7DF4D62ADQ40525399-AFECE8D9-6E2E-417D-A1EB-4CDF0A03640CQ40707686-CB181DAF-88E7-4F91-9040-AA67ABFC722BQ40886408-63BEBA39-1DF6-4A8C-94B2-3B5595FE5855Q41073121-49F6AD29-8B1E-48C5-AAD8-91677FFE9D70Q41372349-4C4FBAD6-88E8-48D7-B284-130FD31E5780Q41433212-15A08629-59A1-4251-AC6C-A9F833BC363AQ41991746-04BB5E6C-DB8E-4FC4-8413-070FEED2702CQ42270339-29171108-E6A8-4E5A-AC0F-CD4FEFC7A8E0Q42366693-59C77E1F-B7A6-4702-BF36-7A9CC5F2C478Q42558984-C51E786A-23BF-4458-A443-D92A843BA1B1Q44042237-E3FBC97B-A0B2-4A6A-9A39-E4B50B533A04Q51320861-2E386EFD-C60B-4175-AABC-02327373CE28
P2860
Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Risk factors for extended-spec ...... ired urinary tract infections.
@en
Risk factors for extended-spec ...... ired urinary tract infections.
@nl
type
label
Risk factors for extended-spec ...... ired urinary tract infections.
@en
Risk factors for extended-spec ...... ired urinary tract infections.
@nl
prefLabel
Risk factors for extended-spec ...... ired urinary tract infections.
@en
Risk factors for extended-spec ...... ired urinary tract infections.
@nl
P2093
P1476
Risk factors for extended-spec ...... ired urinary tract infections.
@en
P2093
F Timurkaynak
K Serefhanoğlu
S Colakoğlu
S S Senger
P304
P356
10.1111/J.1469-0691.2009.02941.X
P577
2009-08-18T00:00:00Z